Catalyst Wire Dossier Catalyst Wire Dossier

Radiation sensitizer (oral)

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Radiation sensitizer (oral), covering 2017-05-31 to 2017-05-31. Get the full timeline:

Most recent: Clinical Trial Update: The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC) [Phase 2]

See pricing